R. Scott

Intracoronary photodynamic therapy reduces neointimal growth without suppressing re-endothelialisation in a porcine model

R. Pakala, R. Waksman, R. Grove, 2006, Heart.

A potential new radiopharmaceutical for parathyroid imaging: radiolabeled parathyroid-specific monoclonal antibody--I. Evaluation of 125I-labeled antibody in a nude mouse model system.

M. Welch, W. Cance, S. Wells, 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

A potential new radiopharmaceutical for parathyroid imaging: radiolabeled parathyroid-specific monoclonal antibody--II. Comparison of 125I- and 111In-labeled antibodies.

M. Welch, W. Cance, S. Wells, 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression.

Steven J. Rychnovsky, Travis I. Moore, Renu Virmani, 2008, Journal of the American College of Cardiology.

Absence of bacterial resistance following repeat exposure to photodynamic therapy

Robert Scott, Cale Street, Lisa Pedigo, 2009, World Congress of the International Photodynamic Association.

PhotoPoint photodynamic therapy with local drug delivery eliminates vessel wall cells in arteriovenous graft models.

R. Grove, J. Freischlag, M. Farooq, 2002, Cardiovascular radiation medicine.

Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial ☆ ☆☆

T. Callister, P. Raggi, G. Bachmann, 2001 .